Kimia Bioscien.

58
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
30.41
-0.66 (-2.12%)
BSENSE

Nov 20

BSE+NSE Vol: 1.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -3.39% vs 13.39% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -29.54% vs 4,289.04% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -22.85% vs -9.76% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -22.67% vs 281.07% in Mar 2025

Compare Profit and Loss Results of Kimia Bioscien.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
114.00
654.00
-540.00
-82.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
114.00
654.00
-540.00
-82.57%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
14.00
-10.00
-71.43%
Raw Materials Consumed
65.00
508.00
-443.00
-87.20%
Power & Fuel Cost
5.00
5.00
0.00
0.00%
Employee Cost
12.00
10.00
2.00
20.00%
Operating Expenses
1.00
5.00
-4.00
-80.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
5.00
-1.00
-20.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
100.00
633.00
-533.00
-84.20%
Operating Profit (PBDIT) excl Other Income
14.00
21.00
-7.00
-33.33%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
15.00
21.00
-6.00
-28.57%
Interest
3.00
2.00
1.00
50.00%
Profit before Depriciation and Tax
12.00
18.00
-6.00
-33.33%
Depreciation
3.00
4.00
-1.00
-25.00%
Profit Before Taxation & Exceptional Items
8.00
14.00
-6.00
-42.86%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
14.00
-6.00
-42.86%
Provision for Tax
1.00
3.00
-2.00
-66.67%
Profit After Tax
7.00
10.00
-3.00
-30.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
-10.00
10.00
100.00%
Profit Available for appropriations
6.00
0.00
6.00
0%
Appropriations
6.00
0.00
6.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.64
2.23
-0.59
-26.46%
Profit And Loss - Net Sales
Net Sales 114.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.39% vs 13.39% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.27 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -29.54% vs 4,289.04% in Mar 2025

Profit And Loss - Interest
Interest 3.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -22.85% vs -9.76% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 7.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -22.67% vs 281.07% in Mar 2025